Welcome to
the recruiting website
for The STRIDE Study.


Our research study of an investigational drug for people with plantar fibromatosis, also called Ledderhose disease or “Dupuytren's disease of the foot.”

In The STRIDE Study, we are evaluating an investigational drug called EN3835 for the treatment of nodules on the bottom of the foot from plantar fibromatosis.

Pre-Qualifying Questionnaire


To see if you may qualify for The STRIDE Study, please complete this Pre-Qualifying Questionnaire.

By clicking to begin the pre-screening process, you allow us to proceed with the pre-screening questions and to begin recording your answers. By clicking you also agree to the terms of the Privacy Policy.

Your name and contact information will not be associated with your answers unless you provide this information after you complete the pre-qualifying questionnaire.

1 Has a health care professional told you that you have plantar fibromatosis (also called Ledderhose disease or Dupuytren’s disease of the foot)?
 
 Yes   No   Unsure 
2 Are you currently experiencing foot pain due to plantar fibromatosis?
 
 Yes   No   Unsure 
3 Are you 18 years of age or above?
 
 Yes   No 
4 How did you hear about this research study
 
5 Please enter your home or work zip code. This zip code will be used to locate a study center near you. Please provide the zip code that would be most convenient to you.
 
Enter 5-digit zip code


Right now, we are looking for people ages 18 and up with current foot pain due to plantar fibromatosis to participate in our research study. If you have been diagnosed with plantar fibromatosis and have one or two painful nodules in (in or on) the bottom of your foot, please continue reading to learn about potential participation in The STRIDE Study.

To see if there is a STRIDE study center in a city near you, please review the list below then complete the pre-qualification questionnaire on the home page.

If you would like to learn more about The STRIDE Study or participation in clinical research studies in general, please scroll down or click on the page links listed above.

To see if you may qualify to participate in our study, please take our pre-qualification questionnaire. If you prequalify on the questionnaire, you will have the option to submit your contact information to the nearest participating study center. If you submit your information, the study center staff will contact you for additional information. Based on this information, you may be asked to come to the study center to undergo additional assessments to determine whether you are eligible for the study. You are not obligated to participate in the study at any point in the process.


SEE IF I PRE-QUALIFY

Participating Cities

  • Arizona
    •  Mesa
    •  Scottsdale
    •  Tucson
  • California
    •  Castro Valley
    •  Cerritos
    •  Corona
    •  Encinitas
    •  Fresno
    •  Lancaster
    •  Los Angeles
    •  San Francisco
  •  Tarzana
  • Colorado
    •  Johnstown
    •  Parker
  • Florida
    •  Jacksonville
    •  Miami
    •  North Miami Beach
    •  Pinellas Park
    •  South Miami
    •  Sweetwater
  • Georgia
    •  Lawrenceville
  • Illinois
    •  O'Fallon
    •  Oakbrook
  • Kansas
    •  Overland Park
  • Louisiana
    •  Shreveport
  • Maryland
    •  Pasadena
  • Missouri
    •  Jefferson City
  • Montana
    •  Billings
    •  Missoula
  • New Jersey
    •  Oradell
    •  Vineland
  • North Carolina
    •  Wilmington
  • Oklahoma
    •  Oklahoma City
    • Pennsylvania
      •  Altoona
      •  State College
    • Puerto Rico
      •  Mayaguez
      •  Ponce
    • Texas
      •  Arlington
      •  Bedford
      •  Burleson
      •  Fort Worth
      •  Georgetown
      •  Humble
      •  McAllen


    About this study
    Why Is The STRIDE Study Important?


    According to the National Institutes of Health, plantar fibromatosis, also called Ledderhose disease, is a disorder that results in the formation of nodules (fibromas) along the plantar fascia, the long ligament stretching from the heel to the toes. These nodules can cause pain, problems with walking and daily functioning, and decreased quality of life.

    There is currently no available therapy that can impact disease progression. Current treatment of plantar fibromatosis is aimed at symptom relief and can vary depending on the severity of the disease. To help reduce the symptoms caused by plantar fibromatosis, doctors have a few options when prescribing treatment strategies. However, these treatments may not work for everyone with plantar fibromatosis. When conservative treatments fail, surgical removal of the nodules is often performed. However, recurrence of the nodules may occur even after surgical treatments.

    For these reasons, it is important that doctors and scientists continue the search for new treatments for plantar fibromatosis.

    Before investigational medications can be approved for public use, they must be tested in research studies like this one. If you have one or two painful nodules on the bottom of one foot from plantar fibromatosis, please consider participating in The STRIDE Study.

    SEE IF I PRE-QUALIFY


    About this study
    What Is Clinical Research?


    A research study (sometimes called “clinical research” or a “clinical trial”) is generally considered to be health-related research in people who have a specific condition, which uses a pre-defined written set of instructions and guidelines (the “protocol”) for how the study is to be conducted.

    CLICK HERE TO LEARN MORE